For those interested in deeper, more restorative rest, DSIP offers a promising angle by supporting sleep architecture rather than forcing drowsiness
October 2, 2024: FDA Issues Concerns Over Unapproved GLP-1 Drugs for Weight Loss The U.S
ADVANCE Collaborative Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
Effects of endogenous GLP-1 have been better characterized using the receptor antagonist exendin-(9-39)
The reason may be that the high-lipid diet induced oxidative stress (Raghuvaran et al., 2023) and inflammation (Dai et al., 2022), which in turn affected the intestinal development
[DOI] [PubMed] [Google Scholar] 31.Ramnanan CJ, Edgerton DS, Kraft G, et al